Hem › Icke-småcellig lungcancer › Kansas › Overland Park
Kliniska studier för Icke-småcellig lungcancer i Overland Park, KS
16 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Overland Park (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RekryterarFas 1/2
- Kansas City Cancer Center /ID# 273679, Overland Park
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
RekryterarFas 3
- Research Site, Leawood · 3 mi bort
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekryterarFas 2
- University of Kansas Cancer Center, Fairway · 3 mi bort
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekryterarFas 3
- Saint Luke's South Hospital, Overland Park
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekryterarFas 2/3
- MidAmerica Cancer Care - Research, Merriam · 3 mi bort
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekryterarFas 3
- University of Kansas Cancer Center-Overland Park, Overland Park
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekryterarFas 1
- The University of Kansas Cancer Center - Indian Creek Campus, Overland Park
- The University of Kansas Cancer Center, Investigational Drug Services, Fairway · 3 mi bort
- The University of Kansas Clinical Research Center, Fairway · 3 mi bort
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekryterarFas 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi bort
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi bort
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2/3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi bort
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi bort
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekryterarFas 1/2
- The University of Kansas Cancer Center, Fairway · 3 mi bort
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekryterarObservationsstudie
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
RekryterarFas 1/2
- The University of Kansas Cancer Center (KUCC), Fairway · 3 mi bort
A Study of IBI363 in Subjects with Advanced Solid Malignancies
RekryterarFas 2
- University of Kansas Medical Center (KUMC), Fairway · 3 mi bort
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
RekryterarObservationsstudie
- The University of Kansas Cancer Center (KUCC), Fairway · 3 mi bort
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andra studier i Overland Park
- Akut myeloid leukemi11 studier
- Lungcancer11 studier
- Bröstcancer10 studier
- Atrial fibrillation8 studier
- Kolorektal cancer8 studier
- Övervikt7 studier
- Bukspottkörtelcancer7 studier
- Prostatacancer7 studier
- Melanom6 studier
- Övervikt6 studier
- Äggstockscancer6 studier
- Cancer (alla typer)5 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.